The rapidly changing landscape in mature T‐cell lymphoma (MTCL) biology and management
Published 2019 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
The rapidly changing landscape in mature T‐cell lymphoma (MTCL) biology and management
Authors
Keywords
-
Journal
CA-A CANCER JOURNAL FOR CLINICIANS
Volume 70, Issue 1, Pages 47-70
Publisher
Wiley
Online
2019-12-09
DOI
10.3322/caac.21589
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- SPECIAL UPDATE
- (2019) Mark Magnusson et al. PLASTIC AND RECONSTRUCTIVE SURGERY
- Molecular Drivers of Breast Implant–Associated Anaplastic Large Cell Lymphoma
- (2019) Piers Blombery et al. PLASTIC AND RECONSTRUCTIVE SURGERY
- Epstein-Barr virus strain variation and cancer
- (2019) Teru Kanda et al. CANCER SCIENCE
- The role of autologous stem cell transplantation in patients with nodal peripheral T-cell lymphomas in first complete remission: Report from COMPLETE, a prospective, multicenter cohort study
- (2019) Steven I. Park et al. CANCER
- Phase II Study of the PD-1 Inhibitor Pembrolizumab for the Treatment of Relapsed or Refractory Mature T-cell Lymphoma
- (2019) Stefan K. Barta et al. Clinical Lymphoma Myeloma & Leukemia
- The cancer driver genes IDH1/2, JARID1C/ KDM5C, and UTX/ KDM6A: crosstalk between histone demethylation and hypoxic reprogramming in cancer metabolism
- (2019) Soojeong Chang et al. EXPERIMENTAL AND MOLECULAR MEDICINE
- CLINICAL AND BIOLOGICAL EVALUATION OF THE NOVEL CD30/CD16A TETRAVALENT BISPECIFIC ANTIBODY (AFM13) IN RELAPSED OR REFRACTORY CD30-POSITIVE LYMPHOMA WITH CUTANEOUS PRESENTATION: A BIOMARKER PHASE IB/IIA STUDY (NCT03192202)
- (2019) A. Sawas et al. HEMATOLOGICAL ONCOLOGY
- ORAL 5-AZACYTIDINE AND ROMIDEPSIN EXHIBIT MARKED ACTIVITY IN PATIENTS WITH PTCL: A MULTICENTER PHASE I STUDY
- (2019) Owen A O'Connor et al. BLOOD
- RHOA G17V Induces T Follicular Helper Cell Specification and Promotes Lymphomagenesis
- (2018) Jose R. Cortes et al. CANCER CELL
- Global Prevalence of Celiac Disease: Systematic Review and Meta-analysis
- (2018) Prashant Singh et al. Clinical Gastroenterology and Hepatology
- Histone modifier gene mutations in peripheral T-cell lymphoma not otherwise specified
- (2018) Meng-Meng Ji et al. HAEMATOLOGICA
- Angioimmunoblastic T-cell lymphoma: a prognostic model from a retrospective study
- (2018) Huangming Hong et al. LEUKEMIA & LYMPHOMA
- Histone modifier gene mutations in peripheral T-cell lymphoma not otherwise specified
- (2018) Meng-Meng Ji et al. HAEMATOLOGICA
- Treatment with 5-azacytidine induces a sustained response in patients with angioimmunoblastic T-cell lymphoma
- (2018) François Lemonnier et al. BLOOD
- Brentuximab vedotin with chemotherapy for CD30-positive peripheral T-cell lymphoma (ECHELON-2): a global, double-blind, randomised, phase 3 trial
- (2018) Steven Horwitz et al. LANCET
- Breast Implant-Associated Anaplastic Large Cell Lymphoma
- (2018) P. Rastogi et al. Current Hematologic Malignancy Reports
- Anaplastic lymphoma kinase-positive anaplastic large cell lymphoma with the variant RNF213-, ATIC- and TPM3-ALK fusions is characterized by copy number gain of the rearranged ALK gene
- (2017) Jo-Anne van der Krogt et al. HAEMATOLOGICA
- Dose-adjusted EPOCH chemotherapy for untreated peripheral T-cell lymphomas: a multicenter phase II trial of West-JHOG PTCL0707
- (2017) Yoshinobu Maeda et al. HAEMATOLOGICA
- International Assessment of Event-Free Survival at 24 Months and Subsequent Survival in Peripheral T-Cell Lymphoma
- (2017) Matthew J. Maurer et al. JOURNAL OF CLINICAL ONCOLOGY
- Lymphoma classification update: T-cell lymphomas, Hodgkin lymphomas, and histiocytic/dendritic cell neoplasms
- (2017) Manli Jiang et al. Expert Review of Hematology
- Genetic Landscape and Classification of Peripheral T Cell Lymphomas
- (2017) Rosalind F. Sandell et al. Current Oncology Reports
- Understanding CD30 biology and therapeutic targeting: a historical perspective providing insight into future directions
- (2017) C A van der Weyden et al. Blood Cancer Journal
- Anaplastic lymphoma kinase-positive anaplastic large cell lymphoma with the variant RNF213-, ATIC- and TPM3-ALK fusions is characterized by copy number gain of the rearranged ALK gene
- (2017) Jo-Anne van der Krogt et al. HAEMATOLOGICA
- Dose-adjusted EPOCH chemotherapy for untreated peripheral T-cell lymphomas: a multicenter phase II trial of West-JHOG PTCL0707
- (2017) Yoshinobu Maeda et al. HAEMATOLOGICA
- The 2016 revision of the World Health Organization classification of lymphoid neoplasms
- (2016) S. H. Swerdlow et al. BLOOD
- Racial Patterns of Peripheral T-Cell Lymphoma Incidence and Survival in the United States
- (2016) Scott V. Adams et al. JOURNAL OF CLINICAL ONCOLOGY
- A prognostic index for natural killer cell lymphoma after non-anthracycline-based treatment: a multicentre, retrospective analysis
- (2016) Seok Jin Kim et al. LANCET ONCOLOGY
- Novel ALK fusion in anaplastic large cell lymphoma involving EEF1G, a subunit of the eukaryotic elongation factor-1 complex
- (2016) G Palacios et al. LEUKEMIA
- Variegated RHOA mutations in adult T-cell leukemia/lymphoma
- (2015) Y. Nagata et al. BLOOD
- The combination of hypomethylating agents and histone deacetylase inhibitors produce marked synergy in preclinical models of T-cell lymphoma
- (2015) Enrica Marchi et al. BRITISH JOURNAL OF HAEMATOLOGY
- Convergent Mutations and Kinase Fusions Lead to Oncogenic STAT3 Activation in Anaplastic Large Cell Lymphoma
- (2015) Ramona Crescenzo et al. CANCER CELL
- Preclinical Pharmacologic Evaluation of Pralatrexate and Romidepsin Confirms Potent Synergy of the Combination in a Murine Model of Human T-cell Lymphoma
- (2015) S. Jain et al. CLINICAL CANCER RESEARCH
- Belinostat in Patients With Relapsed or Refractory Peripheral T-Cell Lymphoma: Results of the Pivotal Phase II BELIEF (CLN-19) Study
- (2015) Owen A. O'Connor et al. JOURNAL OF CLINICAL ONCOLOGY
- Phase II Intergroup Trial of Alisertib in Relapsed and Refractory Peripheral T-Cell Lymphoma and Transformed Mycosis Fungoides: SWOG 1108
- (2015) Paul M. Barr et al. JOURNAL OF CLINICAL ONCOLOGY
- The mutational landscape of cutaneous T cell lymphoma and Sézary syndrome
- (2015) Ana Carolina da Silva Almeida et al. NATURE GENETICS
- Panobinostat in combination with bortezomib in patients with relapsed or refractory peripheral T-cell lymphoma: an open-label, multicentre phase 2 trial
- (2015) Daryl Tan et al. Lancet Haematology
- Peripheral T-cell lymphomas in a large US multicenter cohort: prognostication in the modern era including impact of frontline therapy
- (2014) J. S. Abramson et al. ANNALS OF ONCOLOGY
- Gene expression signatures delineate biological and prognostic subgroups in peripheral T-cell lymphoma
- (2014) J. Iqbal et al. BLOOD
- Real-world data on prognostic factors and treatment in peripheral T-cell lymphomas: a study from the Swedish Lymphoma Registry
- (2014) F. Ellin et al. BLOOD
- A Phase II trial of Belinostat (PXD101) in patients with relapsed or refractory peripheral or cutaneous T-cell lymphoma
- (2014) Francine Foss et al. BRITISH JOURNAL OF HAEMATOLOGY
- Final report of a phase 2 clinical trial of lenalidomide monotherapy for patients with T-cell lymphoma
- (2014) Ethan Toumishey et al. CANCER
- Gain-of-functionCCR4mutations in adult T cell leukemia/lymphoma
- (2014) Masao Nakagawa et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Frequent STAT5B mutations in γδ hepatosplenic T-cell lymphomas
- (2014) A Nicolae et al. LEUKEMIA
- Intensified chemo-immunotherapy with or without stem cell transplantation in newly diagnosed patients with peripheral T-cell lymphoma
- (2014) P Corradini et al. LEUKEMIA
- A recurrent inactivating mutation in RHOA GTPase in angioimmunoblastic T cell lymphoma
- (2014) Hae Yong Yoo et al. NATURE GENETICS
- Somatic RHOA mutation in angioimmunoblastic T cell lymphoma
- (2014) Mamiko Sakata-Yanagimoto et al. NATURE GENETICS
- Recurrent mutations in epigenetic regulators, RHOA and FYN kinase in peripheral T cell lymphomas
- (2014) Teresa Palomero et al. NATURE GENETICS
- A targeted mutational landscape of angioimmunoblastic T-cell lymphoma
- (2013) O. Odejide et al. BLOOD
- Enteropathy associated T cell lymphoma in celiac disease: A large retrospective study
- (2013) Georgia Malamut et al. DIGESTIVE AND LIVER DISEASE
- Hematopoietic Cell Transplantation for Systemic Mature T-Cell Non-Hodgkin Lymphoma
- (2013) Sonali M. Smith et al. JOURNAL OF CLINICAL ONCOLOGY
- Survival of Patients With Peripheral T-Cell Lymphoma After First Relapse or Progression: Spectrum of Disease and Rare Long-Term Survivors
- (2013) Vivien Mak et al. JOURNAL OF CLINICAL ONCOLOGY
- JAK3 deregulation by activating mutations confers invasive growth advantage in extranodal nasal-type natural killer cell lymphoma
- (2013) A Bouchekioua et al. LEUKEMIA
- Preemptive leucovorin administration minimizes pralatrexate toxicity without sacrificing efficacy
- (2013) Ellen Koch et al. LEUKEMIA & LYMPHOMA
- STAT3 mutations unify the pathogenesis of chronic lymphoproliferative disorders of NK cells and T-cell large granular lymphocyte leukemia
- (2012) A. Jerez et al. BLOOD
- Recurrent TET2 mutations in peripheral T-cell lymphomas correlate with TFH-like features and adverse clinical parameters
- (2012) F. Lemonnier et al. BLOOD
- IDH2 mutations are frequent in angioimmunoblastic T-cell lymphoma
- (2012) R. A. Cairns et al. BLOOD
- Brentuximab Vedotin (SGN-35) in Patients With Relapsed or Refractory Systemic Anaplastic Large-Cell Lymphoma: Results of a Phase II Study
- (2012) Barbara Pro et al. JOURNAL OF CLINICAL ONCOLOGY
- Up-Front Autologous Stem-Cell Transplantation in Peripheral T-Cell Lymphoma: NLG-T-01
- (2012) Francesco d'Amore et al. JOURNAL OF CLINICAL ONCOLOGY
- Results From a Pivotal, Open-Label, Phase II Study of Romidepsin in Relapsed or Refractory Peripheral T-Cell Lymphoma After Prior Systemic Therapy
- (2012) Bertrand Coiffier et al. JOURNAL OF CLINICAL ONCOLOGY
- Results From a Prospective, Open-Label, Phase II Trial of Bendamustine in Refractory or Relapsed T-Cell Lymphomas: The BENTLY Trial
- (2012) Gandhi Damaj et al. JOURNAL OF CLINICAL ONCOLOGY
- SomaticSTAT3Mutations in Large Granular Lymphocytic Leukemia
- (2012) Hanna L.M. Koskela et al. NEW ENGLAND JOURNAL OF MEDICINE
- TET2andDNMT3AMutations in Human T-Cell Lymphoma
- (2012) Lucile Couronné et al. NEW ENGLAND JOURNAL OF MEDICINE
- Janus Kinase 3–Activating Mutations Identified in Natural Killer/T-cell Lymphoma
- (2012) Ghee Chong Koo et al. Cancer Discovery
- Molecular Hallmarks of Adult T Cell Leukemia
- (2012) Makoto Yamagishi et al. Frontiers in Microbiology
- Adult T-Cell Leukemia: A Review of Epidemiological Evidence
- (2012) Masako Iwanaga et al. Frontiers in Microbiology
- Peripheral T-cell lymphoma, not otherwise specified: a report of 340 cases from the International Peripheral T-cell Lymphoma Project
- (2011) D. D. Weisenburger et al. BLOOD
- Phase 2 trial of romidepsin in patients with peripheral T-cell lymphoma
- (2011) R. L. Piekarz et al. BLOOD
- Pralatrexate in Patients With Relapsed or Refractory Peripheral T-Cell Lymphoma: Results From the Pivotal PROPEL Study
- (2011) Owen A. O'Connor et al. JOURNAL OF CLINICAL ONCOLOGY
- Allogeneic hematopoietic cell transplant for peripheral T-cell non-Hodgkin lymphoma results in long-term disease control
- (2011) Jasmine Zain et al. LEUKEMIA & LYMPHOMA
- TET1 and hydroxymethylcytosine in transcription and DNA methylation fidelity
- (2011) Kristine Williams et al. NATURE
- Treatment and prognosis of mature T-cell and NK-cell lymphoma: an analysis of patients with T-cell lymphoma treated in studies of the German High-Grade Non-Hodgkin Lymphoma Study Group
- (2010) N. Schmitz et al. BLOOD
- Allogeneic haematopoietic cell transplantation after nonmyeloablative conditioning in patients with T-cell and natural killer-cell lymphomas
- (2010) Andrei R. Shustov et al. BRITISH JOURNAL OF HAEMATOLOGY
- Natural killer cell lymphoma shares strikingly similar molecular features with a group of non-hepatosplenic γδ T-cell lymphoma and is highly sensitive to a novel aurora kinase A inhibitor in vitro
- (2010) J Iqbal et al. LEUKEMIA
- FDA approves pralatrexate for treatment of rare lymphoma
- (2009) Cheryl A. Thompson AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY
- High-dose CHOP plus etoposide (MegaCHOEP) in T-cell lymphoma: a comparative analysis of patients treated within trials of the German High-Grade Non-Hodgkin Lymphoma Study Group (DSHNHL)
- (2009) M. Nickelsen et al. ANNALS OF ONCOLOGY
- Gene expression profiling identifies emerging oncogenic pathways operating in extranodal NK/T-cell lymphoma, nasal type
- (2009) Y. Huang et al. BLOOD
- A Phase II study of SGN-30 (anti-CD30 mAb) in Hodgkin lymphoma or systemic anaplastic large cell lymphoma
- (2009) Andres Forero-Torres et al. BRITISH JOURNAL OF HAEMATOLOGY
- Laboratory correlates for a phase II trial of romidepsin in cutaneous and peripheral T-cell lymphoma
- (2009) Susan E. Bates et al. BRITISH JOURNAL OF HAEMATOLOGY
- Phase II-I-II Study of Two Different Doses and Schedules of Pralatrexate, a High-Affinity Substrate for the Reduced Folate Carrier, in Patients With Relapsed or Refractory Lymphoma Reveals Marked Activity in T-Cell Malignancies
- (2009) Owen A. O'Connor et al. JOURNAL OF CLINICAL ONCOLOGY
- Allogeneic Stem Cell Transplantation Is Able to Induce Long-Term Remissions in Angioimmunoblastic T-Cell Lymphoma: A Retrospective Study From the Lymphoma Working Party of the European Group for Blood and Marrow Transplantation
- (2009) Charalampia Kyriakou et al. JOURNAL OF CLINICAL ONCOLOGY
- STAT3 transcription factor is constitutively activated and is oncogenic in nasal-type NK/T-cell lymphoma
- (2009) P Coppo et al. LEUKEMIA
- Mutation inTET2in Myeloid Cancers
- (2009) François Delhommeau et al. NEW ENGLAND JOURNAL OF MEDICINE
- Intensive chemotherapy (high-dose CHOP/ESHAP regimen) followed by autologous stem-cell transplantation in previously untreated patients with peripheral T-cell lymphoma
- (2008) S. Mercadal et al. ANNALS OF ONCOLOGY
- Determination of the class and isoform selectivity of small-molecule histone deacetylase inhibitors
- (2008) Nagma Khan et al. BIOCHEMICAL JOURNAL
- International Peripheral T-Cell and Natural Killer/T-Cell Lymphoma Study: Pathology Findings and Clinical Outcomes
- (2008) JOURNAL OF CLINICAL ONCOLOGY
- Autologous Stem-Cell Transplantation As First-Line Therapy in Peripheral T-Cell Lymphomas: Results of a Prospective Multicenter Study
- (2008) Peter Reimer et al. JOURNAL OF CLINICAL ONCOLOGY
- Incidence and outcomes of the peripheral T-cell lymphoma subtypes in the United States
- (2008) Abeer N. Abouyabis et al. LEUKEMIA & LYMPHOMA
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started